Effects of enzyme inducers or inhibitors on the pharmacokinetics of intravenous parathion in rats

Biopharmaceutics and Drug Disposition

Volumn 21, Issue 5, 2000, Pages 193-204

  Hurh, Eunju ^a   Lee, Eun J ^a   Lee, Ae K ^a   Kim, Yoon G ^a   Kim, So H ^a   Kim, Sang G ^a   Lee, Myung G ^a  

^a Seoul National University   (South Korea)

Author keywords

CYP3A23; Enzyme inducers or inhibitors; Michaelis Menten constants; Paraoxon; Parathion; Pharmacokinetics

Indexed keywords

3 METHYLCHOLANTHRENE; CYTOCHROME P450; DEXAMETHASONE; ENZYME INDUCING AGENT; ENZYME INHIBITOR; ISONIAZID; KETOCONAZOLE; PARAOXON; PARATHION; PHENOBARBITAL; PROADIFEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG METABOLISM; DRUG TRANSFORMATION; JUGULAR VEIN; LIVER MICROSOME; MALE; NONHUMAN; RAT; WESTERN BLOTTING;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BLOTTING, WESTERN; CYTOCHROME P-450 ENZYME SYSTEM; DEXAMETHASONE; DRUG INTERACTIONS; ENZYME INDUCTION; ENZYME INHIBITORS; INSECTICIDES; ISOENZYMES; ISONIAZID; KETOCONAZOLE; MALE; METHYLCHOLANTHRENE; MICROSOMES, LIVER; PARAOXON; PARATHION; PHENOBARBITAL; PROADIFEN; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 0034494371     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-081X(200007)21:5<193::AID-BDD229>3.0.CO;2-6     Document Type: Article

References (42)

1. Uptake, clearance, and metabolism of parathion by perfused whole pig livers
2. Disposition of parathion in neonatal and young pigs
3. Biotransformation of parathion in human liver: Intraperitoneal injection of CYP3A4 and its inactivation during microsomal parathion oxidation
4. The effects of phenobarbital pretreatment on the metabolism and acute toxicity of the pesticide parathion in the mouse
5. Effect of phenobarbital and/or SKF 525-A on the metabolism and acute toxicity of parathion in adult female rats
6. A major glucocorticoid-inducible P450 in rat liver is not P450 3A1
7. Involvement of cytochrome P4502E1 in the toxicity of dichloropropanol to rat hepatocyte cultures
8. Rat and human liver cytochromes P450. Substrate and inhibitor specificities and functional markers
9. Differential activities of CYP1A isozymes in hepatic and intestinal microsomes of control and 3-methylcholanthreneinduced rats
10. Phosphorylation/dephosphorylation steps are crucial for the induction of CYP2B1 and CYP2B2 gene expression by phenobarbital
11. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes
12. Environmental factors influencing drug metabolism
13. Mechanism of ketoconazole-induced elevation of individual serum bile acids in the rat: Relationship to the effect of ketoconazole on bile acid uptake by isolated hepatocytes
14. Studies on the pregnenolone-16α-carbonitrile-inducible form of rat liver microsomal cytochrome P-450 and UDP-glucuronosyl transferase
15. Formation of ligand and metabolite complexes as a means for selective quantitation of cytochrome P450 isozymes
16. Characterization of a major form of rat hepatic microsomal cytochrome P-450 induced by isoniazid
17. Effect of phenobarbital and 3-methylcholanthrene pretreatment on the pharmacokinetics and pharmacodynamics of furosemide in rats
18. Effect of phenobarbital and 3-methylcholanthrene pretreatment on the plasma half-life and urinary excretion profile of theophylline and its metabolites in rats
19. Protein measurement with the Folin phenol reagent
20. Cleavage of structural proteins during assembly of the head of the bacteriophage T4
21. c2 and microsomal epoxide hydrolase gene by thiazole, benzothiazole and benzothiadiazole
22. Molecular mechanism for alkyl sulfide-modulated carbon tetrachloride-induced hepatotoxicity: The role of P450 2E1, P450 2B and glutathione S-transferase expression
23. Comparison of assay methods for studying O,O-diethyl-O-p-nitrophenyl phosphate (paraoxon) detoxification in vitro
24. Intrinsic metabolic clearance of parathion and paraoxon by livers from fish and rodents
25. The determination of enzyme dissociation constants
26. Percutaneous absorption, biotransformation, and systemic disposition of parathion in vivo in swine. I. Comprehensive pharmacokinetic model
27. Critical evaluation of potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve
28. Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition
29. New calculation method of mean total body clearance of drugs and its application to dosage regimens
30. New calculation method for mean apparent drug volume of distribution and application to rational dosage regimens
31. Pharmacokinetics of diazepam following multiple dose oral administration to healthy human subjects
32. Hemoperfusion and pharmacokinetic studies with parathion and paraoxon in the rat and dog
33. Studies on the metabolism of diethyl 4-nitrophenyl phosphorothionate (parathion) in vitro
34. Toxicokinetics of methyl parathion and parathion in the dog after intravenous and oral administration
35. 14C]paraoxon in isolated, perfused rat livers
36. A physiological approach to hepatic drug clearance
37. Differential effects of hepatic microsomal enzyme inducing agents on liver blood flow
38. Effects of alteration of hepatic microsomal enzyme activity on liver blood flow in the rat
39. Changes in liver blood flow during enzyme induction
40. Hepatic blood flow and enzyme induction in the rat
41. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats